UBS Downgrades Braskem to Sell, Lowers Price Target to $1.5

Benzinga Newsdesk www.benzinga.com Negative 89.0%

Neg 89% Neu 0% Pos 0%

UBS analyst Tasso Vasconcellos downgrades Braskem (NYSE:BAK) from Neutral to Sell and lowers the price target from $4 to $1.5.